In July, the company said it was realigning its business to focus on its fast-growing Baby Care division and would “closely examine all strategic options for the future of its 51% subsidiary Pharmalys.”
It announced the Dairy Ingredients division will divest its production plant in Germany and develop a new strategy, and the company's Cereals & Ingredients division would be discontinued due to a lack of critical size and scalability; some of its business activities will be integrated into Dairy Ingredients or divested.
The sale will take place retroactively to June 30, 2019. The transaction details will be published in the company’s half-year report on August 20, 2019.
The Hochdorf Group achieved a consolidated gross sales revenue of CHF 561m ($576m) in 2018.